<DOC>
	<DOCNO>NCT01951898</DOCNO>
	<brief_summary>Montelukast one anti-inflammatory agent good controller patient asthma . The hypothesis study Montelukast airway anti-inflammatory effect up-regulated regulatory T cell function asthma .</brief_summary>
	<brief_title>Effects Montelukast Airway Regulatory T Cells Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>asthma mild status stable status nonsmoker Positive airway hyperresponsiveness ( MethacholinePC20 &lt; 16mg/mL ) take asthmatic medication oral , injective , inhaled steroid , leukotriene antagonist , oral , inhaled , transdermal betaagonists , theophylline , antihistamine agent , antiIgE antibody long act muscarinic receptor antagonist . respiratory tract infection within 4wks moderate severe organ disorder active malignancy past history side effect leukotriene antagonist psychological disorder pregnancy nurse</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>asthma</keyword>
	<keyword>regulatory T cell</keyword>
	<keyword>leukotriene antagonist</keyword>
</DOC>